← Back to headlines

Raymond James Rates Aktis as a 'Strong Buy'
Raymond James has issued a 'Strong Buy' rating for Aktis, citing the potential of its therapeutic platform.
16 Jun, 16:28 — 16 Jun, 16:28
Sources
Showing 1 of 1 sources

Raymond James has issued a 'Strong Buy' rating for Aktis, citing the potential of its therapeutic platform.